TechnoPhage, SA - From science to innovative biopharmaceuticals
TechnoPhage is one of the Founding Members of BEAM ALLIANCE, the newly launched alliance of Biotech’s of Europe innovating in Anti-Microbial Resistance.
CEO of TechnoPhage, Miguel Garcia, was an invited Speaker at the 2nd International hands-on PHAGE BIOTECHNOLOGY course at University of Minho, Braga
R&D Director of TechnoPhage, Sofia Côrte-Real, was an invited Speaker at the workshop B2B Bench-to-Bedside from GEDII that took place at Pousada do Freixo in Oporto city
New patent granted to TechnoPhage/Lusomedicamenta Title: Antibacterial Phage Peptides And Methods Of Use Thereof Office: Japan Patent Office Date: 17-04-2015 Patent No. 5732397

2019 events

18th Fraunhofer Seminar "Models of Lung Disease"
Hannover, Germany. January 24 - 25, 2019

Phage Futures Congress
Washington DC. January 29-30, 2019

Bacteriophage Therapy Summit
Boston, MA. March 26-27, 2019

29th European Congress of Clinical Microbiology & Infectious Diseases (ECCMID)
Amsterdam, Netherlands. April 13-16, 2019